Kleanthis Manousaridis1, Silvia Peter, Stefan Mennel. Show Affiliations » 1. Ophthalmology Department, State Hospital Feldkirch, Feldkirch, Austria.
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAngiogenesis Inhibitors/therapeutic useAntibodies, Bacterial/bloodAntibodies, Monoclonal, Humanized/therapeutic useBartonella henselae/immunologyBartonella henselae/isolation & purificationCat-Scratch Disease/diagnosisCat-Scratch Disease/drug therapyCat-Scratch Disease/microbiologyEye Infections, Bacterial/diagnosisEye Infections, Bacterial/drug therapyEye Infections, Bacterial/microbiologyFemaleFluorescein AngiographyHumansImmunoglobulin G/bloodIntravitreal InjectionsMacular Edema/diagnosisMacular Edema/drug therapyMacular Edema/microbiologyRanibizumabTomography, Optical CoherenceVascular Endothelial Growth Factor A/antagonists & inhibitorsVisual Acuity
Substances： See more » Angiogenesis InhibitorsAntibodies, BacterialAntibodies, Monoclonal, HumanizedImmunoglobulin GVEGFA protein, humanVascular Endothelial Growth Factor ARanibizumab
Year: 2014 PMID： 24943325 DOI： 10.1111/aos.12489
Source DB: PubMed Journal: Acta Ophthalmol ISSN： 1755-375X Impact factor: 3.761